logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Sjoukje F. Oosting

University of Groningen
H指数:43
被引数:9,742

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reporting health-related quality of life in randomised clinical trials evaluating adjuvant systemic therapy: recommendations of Common-Sense Oncology and the European Organisation for Research and Treatment of Cancer

报告辅助全身治疗随机临床试验中的健康相关生活质量：常识肿瘤学和欧洲癌症研究与治疗组织的建议

Lancet Oncology
IF35.9
2026-09-290
PRE
Ian F Tannock; Michael Brundage; Christopher M Booth; Nathan I Cherny; Corneel Coens; Elizabeth A Eisenhauer; Jan Geissler; Johannes M Giesinger; Bishal Gyawali; Sjoukje F Oosting; Gregory R Pond; Jaap C Reijneveld; Enrique Soto-Perez-de-Celis; Michelle Tregear; Winette T A van der Graaf; Brooke E Wilson; Madeline L Pe
Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment

程序性死亡配体1（PD-L1）PET/CT成像评估阿特珠治疗期间肿瘤饱和度

British Journal of Cancer
IF6.8
2026-09-100
OAAI
Jahlisa S. Hooiveld-Noeken; Pim P. van de Donk; Laura Kist de Ruijter; Iris C. Kok; Claudia A. J. van Winkel; Danique Giesen; Marjolijn N. Lub-de Hooge; Adrienne H. Brouwers; Sjoukje F. Oosting; Frederike Bensch; Lotte M. Smit; Carolien P. Schröder; Mathilde Jalving; Sjoerd G. Elias; Jourik A. Gietema; Regula J. Deurloo; Simon P. Williams; Alexander Ungewickell; Derk-Jan A. de Groot; Elisabeth G. E. de Vries
Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck

可切除的头颈部鳞状细胞癌新辅助免疫治疗的目标和反应标准的标准化

Cancer Treatment Reviews
IF10.5
2026-06-240
OAAI
Carlo Resteghini; Athanassios Argiris; Pierre Blanchard; Irene Braña; Anna Maria Camarda; Anthony T.C. Chan; Robert Ferris; Vincent Gregoire; Kevin J. Harrington; Ingeborg Tinhofer; Senada Koljenović; Nancy Y. Lee; C. René Leemans; Jean-Pascal Machiels; Hisham Mehanna; Robert Metcalf; Brian O'Sullivan; Sjoukje Oosting; Ester Orlandi; Vinidh Paleri
Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial

曲美木单抗联合或不联合度伐利尤单抗，与紫杉醇联用治疗转移性尿路上皮癌：ICRA I/II期临床试验

Nature Communications
IF15.7
2026-06-170
OAAI
Sarah M. H. Einerhand; Hamza Ali; Stephen Q. Wong; Jeroen van Dorp; Tatum van Maanen; Jeantine M. de Feijter; Maurits L. van Montfoort; Thierry N. Boellaard; Linde M. Braaf; Wim Brugman; Daniel J. Vis; Cindy M. J. Hollander; Antonios Daletzakis; Helga A. Schrijver; Karen Snapper; Sjoukje F. Oosting; Cheryl P. Bruijnen; Lodewyk F. A. Wessels; Keith S. Chan; Britt B. M. Suelmann; Michiel S. van der Heijden
Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review

乳头状肾细胞癌——基于中央病理学审查的SUNNIFORECAST试验探索性结果：比较伊匹木单抗联合纳武利尤单抗与标准护理作为一线治疗的疗效

European Journal of Cancer
IF7.1
2026-05-270
OAAI
Marit Ahrens; John Haanen; Laurence Albiges; Marine Gross Goupil; Ekaterini Boleti; Gwenaelle Gravis; Aude Fléchon; Marc Oliver Grimm; Jens Bedke; Philippe Barthélémy; Daniel Castellano; Begona Mellado; Philipp Ivanyi; Sylvie Rottey; Anne Flörcken; Cristina Suárez; Jose P. Maroto; Viktor Grünwald; Sjoukje Oosting; Jindrich Kopecky
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of Cancer

在晚期癌症临床试验中报告与健康相关的生活质量数据时，应答者标准的重要性：常识肿瘤学与欧洲癌症研究与治疗组织的建议

lancet oncology
IF0
2025-09-010
PRE
Ian F Tannock; Madeline Lee Pe; Christopher M Booth; Michael Brundage; Nathan I Cherny; Corneel Coens; Elizabeth A Eisenhauer; Jan Geissler; Johannes M Giesinger; Bishal Gyawali; Sjoukje F Oosting; Gregory R Pond; Jaap C Reijneveld; Enrique Soto-Perez-de-Celis; Michelle Tregear; Winette T A van der Graaf
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)

ESMO临床获益程度量表2.0版（ESMO-MCBS v2.0）

Annals of Oncology
IF65.4
2025-05-220
PRE
N.I. Cherny; S.F. Oosting; U. Dafni; N.J. Latino; M. Galotti; P. Zygoura; G. Dimopoulou; T. Amaral; J. Barriuso; A. Calles; B. Kiesewetter; C. Gomez-Roca; B. Gyawali; M. Piccart; A. Passaro; F. Roitberg; N. Tarazona; D. Trapani; G. Curigliano; R. Wester; E.G.E. de Vries
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial

非透明细胞肾细胞癌中，伊匹木单抗/纳武利尤单抗对比标准护理的 prospective randomized phase-II trial - SUNNIFORECAST trial 的结果

Annals of Oncology
IF65.4
2025-04-010
OA
L. Bergmann; L. Albiges; M. Ahrens; M. Gross-Goupil; E. Boleti; G. Gravis; A. Fléchon; M.-O. Grimm; J. Bedke; P. Barthélémy; D. Castellano; B. Mellado; P. Ivanyi; S. Rottey; A. Flörcken; C. Suarez; P. Maroto; V. Grünwald; S.F. Oosting; J. Kopecky; S. Zschäbitz; M. Boegemann; T. Buchler; G. Niegisch; P.J. Goebell; T. Waddell; F. Joly; F. Priou; M. Retz; S. Siemer; U. Zimmermann; D. Deckbar; I. Burkholder; A. Hartmann; J.B. Haanen
mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy
FRONTIERS IN IMMUNOLOGY
IF5.9
2024-08-271
OAAI
Gangaev, Anastasia; van Sleen, Yannick; Brandhorst, Nicole; Hoefakker, Kelly; Prajapati, Bimal; Singh, Amrita; Boerma, Annemarie; van der Heiden, Marieke; Oosting, Sjoukje F.; van der Veldt, Astrid A. M.; Hiltermann, T. Jeroen N.; Geurtsvankessel, Corine H.; Dingemans, Anne-Marie C.; Smit, Egbert F.; de Vries, Elisabeth G. E.; Haanen, John B. A. G.; Kvistborg, Pia; van Baarle, Debbie
Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors
ESMO OPEN
IF8.3
2023-08-012
OAAI
Oosting, S. F.; van der Veldt, A. A. M.; Fehrmann, R. S. N.; Bhattacharya, A.; van Binnendijk, R. S.; GeurtsvanKessel, C. H.; Dingemans, A. -M. C.; Smit, E. F.; Hiltermann, T. J. N.; den Hartog, G.; Jalving, M.; Westphal, T. T.; de Wilt, F.; Ernst, S. M.; Boerma, A.; van Zijl, L.; Rimmelzwaan, G. F.; Kvistborg, P.; van Els, C. A. C. M.; Rots, N. Y.; van Baarle, D.; Haanen, J. B. A. G.; de Vries, E. G. E.
The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs
BMC CANCER
IF3.4
2023-07-114
OAAI
Yildirim, Hilin; Widdershoven, Christiaan, V; Aarts, Maureen J. B.; Bex, Axel; Bloemendal, Haiko J.; Bochove-Overgaauw, Deirdre M.; Hamberg, Paul; Herbschleb, Karin H.; van der Hulle, Tom; Lagerveld, Brunolf W.; van Oijen, Martijn G. H.; Oosting, Sjoukje F.; van Thienen, Johannes, V; van der Veldt, Astrid A. M.; Westgeest, Hans M.; Zeijdner, Evelijn E.; Aben, Katja K. H.; van den Hurk, Corina; Zondervan, Patricia J.; Bins, Adriaan D.

研究方向

暂未获取到该数据
E
Elisabeth G.E. de Vries
H 指数:121论文数:1,695被引数:6.7万
J
Johannes A. Langendijk
H 指数:96论文数:1,291被引数:3.4万
J
Jourik A. Gietema
H 指数:70论文数:486被引数:1.7万
A
Adrienne H. Brouwers
H 指数:49论文数:390被引数:8,985
R
Rudolf S.N. Fehrmann
H 指数:51论文数:240被引数:2.0万
M
Marjolijn N. Lub–de Hooge
H 指数:44论文数:312被引数:7,428
G
György B. Halmos
H 指数:45论文数:242被引数:5,772
A
Astrid A.M. van der Veldt
H 指数:44论文数:360被引数:6,888
M
Max J. H. Witjes
H 指数:47论文数:319被引数:7,114
B
Bernard F. A. M. van der Laan
H 指数:52论文数:259被引数:7,687